GDC-0199

 

Topic mentions per year

Topic mentions per year

2013-2017
01220132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ABC294640 is a specific sphingosine kinase 2 (SphK2) inhibitor. The anti-cervical carcinoma activity by ABC294640 was tested in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2017
Review
2017
B-cell lymphoma-2 (BCL-2) family dysfunction and impairment of apoptosis are common in most B-cell lymphoid malignancies… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Review
2015
Review
2015
With the advent of new agents targeting CD20, Bruton's tyrosine kinase, and phosphoinositol-3 kinase for chronic lymphoid… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2015
2015
The latest Annual Meeting of the American Society of Hematology, held in San Francisco, included data on novel-targeted agents… (More)
Is this relevant?
2014
2014
Drug developers are mounting a poly(ADPribose) polymerase (PARP) inhibitor comeback, and a few are now experimenting with a more… (More)
Is this relevant?
2014
2014
n engl j med 370;12 nejm.org march 20, 2014 1162 2. Mössner E, Brünker P, Moser S, et al. Increasing the efficacy of CD20… (More)
Is this relevant?
2014
2014
Drug developers are mounting a poly(ADPribose) polymerase (PARP) inhibitor comeback, and a few are now experimenting with a more… (More)
Is this relevant?
Review
2013
Review
2013
Despite recent advances in the treatment of chronic lymphocytic leukemia (CLL) with chemoimmunotherapy, many patients with CLL… (More)
Is this relevant?